Nuance, Epic team-up on AI-enabled voice assisted technology
The two companies showcased how ambient clinical documentation can make AI-powered virtual assistant capabilities widely available through Epic apps.
AliveCor’s bloodless hyperkalemia test scores the “Breakthrough Device” designation from the FDA
This means that the agency will consider AliveCor's technology on an accelerated clearance track.
Opternative launches mobile-only vision test
The web-based, voice-activated vision test allows users to renew their prescription online using only a mobile device, even if their prescription has changed.
Dreamit HealthTech’s new cohort includes 7 startups
The following companies have been accepted to the program: Agathos, Asserta Health, CareAdvisors, ImageMover, iQuartic, Mymee and Sana.
Driver launches its platform to connect cancer patients to the best treatments
The new service enables patients, anywhere in the world, to access treatment options across a network of cancer centers without leaving home.
NeuroMetrix unveils Quell 2.0, its next-gen wearable pain relief device
The new device is smarter, 20% more powerful and 50% smaller; also, the companion app has been revamped from the ground up.
IDC: Worldwide wearables up 5.5% due to gains in emerging markets
Asia/Pacific (excluding Japan), Central & Eastern Europe, Middle East & Africa and Latin America grew 14% YoY as basic wristbands are still in high demand.
VA teams-up with DeepMind to use AI to identify health risks for veterans
The partnership will focus on analyzing patterns from around 700,000 historical, de-personalized health records to develop machine learning algorithms.
MINDBODY acquires FitMetrix to add performance tracking to its wellness platform
FitMetrix enables fitness studios and health clubs to integrate digital performance tracking into their locations across several class and equipment types.
Cedars-Sinai, Emulate team-up on a Patient-on-a-Chip program
The technology is designed to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant.









